iguratimod has been researched along with Diffuse Parenchymal Lung Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, J; Fu, X; Han, Q; Liang, Q; Xie, R; Yang, F; Zhang, K; Zheng, Z; Zhu, P | 1 |
| Cai, XN; Lu, L; Ma, H; Shao, SQ; Shu, P; Yin, HQ; Yin, SL; Zhou, DM | 1 |
| Deng, W; Miao, C; Zhang, X | 1 |
3 other study(ies) available for iguratimod and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Iguratimod reduces B-cell secretion of immunoglobulin to play a protective role in interstitial lung disease.
Topics: Animals; B-Lymphocytes; Bleomycin; Chromones; Disease Models, Animal; Humans; Immunoglobulins; Lung; Lung Diseases, Interstitial; Mice; Sulfonamides | 2021 |
Iguratimod attenuates general disease activity and improves lung function in rheumatoid arthritis-associated interstitial lung disease patients.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Chromones; Female; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Respiratory Function Tests; Sulfonamides; Tomography, X-Ray Computed; Young Adult | 2021 |
Abrupt generalized pustules in patients with rheumatoid arthritis and interstitial lung disease.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Arthritis, Rheumatoid; Biopsy; Chromones; Cyclosporine; Diagnosis, Differential; Exanthema; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Paeonia; Plant Extracts; Prednisone; Psoriasis; Skin; Sulfonamides | 2018 |